Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease

Prog Brain Res. 1990:84:333-46. doi: 10.1016/s0079-6123(08)60917-6.
No abstract available

MeSH terms

  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / chemically induced
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / physiopathology
  • Animals
  • Avoidance Learning / drug effects
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiology*
  • Cerebral Cortex / physiopathology
  • Choline O-Acetyltransferase / metabolism
  • Corticotropin-Releasing Hormone / metabolism
  • Cysteamine / pharmacology
  • Disease Models, Animal
  • Dopamine / metabolism
  • Hydroxydopamines
  • Ibotenic Acid
  • Male
  • Norepinephrine / metabolism
  • Oxidopamine
  • Physostigmine / pharmacology
  • Physostigmine / therapeutic use*
  • Rats
  • Rats, Inbred Strains
  • Reference Values
  • Serotonin / metabolism
  • Somatostatin / metabolism

Substances

  • Hydroxydopamines
  • Ibotenic Acid
  • Serotonin
  • Somatostatin
  • Cysteamine
  • Oxidopamine
  • Corticotropin-Releasing Hormone
  • Physostigmine
  • Choline O-Acetyltransferase
  • Acetylcholinesterase
  • Dopamine
  • Norepinephrine